|File:Ethylphenidate 3d spin.gif|
|Systematic (IUPAC) name|
|Metabolism||Hepatic transesterification of prodrugs methylphenidate and ethanol|
|Biological half-life||Dependent on methylphenidate administration.|
|Molar mass||247.33274 g/mol[[Script error: No such module "String".]]|
|Script error: No such module "collapsible list".|
Ethylphenidate (EP) is a potent psychostimulant that acts as both a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain, by binding to, and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft.
It is most commonly formed when ethanol and methylphenidate are coingested, via hepatic transesterification. Ethylphenidate formation appears to be more common when large quantities of methylphenidate and alcohol are consumed at the same time, such as in non-medical use or overdose scenarios. This carboxylesterase-dependent transesterification process is also known to occur when cocaine and alcohol are consumed together, forming cocaethylene.
Ethylphenidate is more selective to the dopamine transporter (DAT) than methylphenidate, having approximately the same efficacy as the parent compound, but has significantly less activity on the norepinephrine transporter (NET). It has a near-identical dopaminergic pharmacodynamic profile as methylphenidate, which is primarily responsible for its euphoric and reinforcing effects.
|Compound||Binding DAT||Binding NET||Uptake DA||Uptake NE|
TEP is less stimulatory than TMP at 5mg/kg, although both compounds generalize at 10mg/kg. This is suggestive of a noradrenergic stimulatory effect present for TMP at lower doses.
Metabolism of dl-TMP coingested with ethanol
The fate of racemic-TMP does to some extent depend on whether it is subjected to first pass metabolism or not.
The para-hydroxy metabolite of l-TMP is important since this accumulates in the brain, whereas l-ritalinic acid does not.
Depending on the study chosen, rac-TMP is 75% the strength of d-TMP. If levo-TMP were completely inactive it would be expected that rac-TMP should only be 50% the strength of dextro-TMP.
Racemic-TMP is enantioselectively converted, only the inactive isomer, l-TMP forms appreciable amounts of ethylphenidate when it is coingested with ethanol, whereas the biologically active eutomer d-TMP does not react with ethanol to any significant extent.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
- Cocaethylene (compound formed when cocaine and ethanol are taken together)
- Ethanol (drinking alcohol)
- Markowitz, JS; Devane, CL; Boulton, DW; Nahas, Z; Risch, SC; Diamond, F; Patrick, KS (2000). "Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol". Drug metabolism and disposition: the biological fate of chemicals. 28 (6): 620–4. PMID 10820132.
- Markowitz, JS; Logan, BK; Diamond, F; Patrick, KS (1999). "Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion". Journal of clinical psychopharmacology. 19 (4): 362–6. doi:10.1097/00004714-199908000-00013. PMID 10440465.
- Bourland, J.; Martin, D.; Mayersohn, M. (1997). "Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of 2H6ethanol: preliminary in vitro findings using a rat liver preparation". Journal of pharmaceutical sciences. 86 (12): 1494–1496. doi:10.1021/js970072x. PMID 9423167.
- Patrick, K.; Williard, R.; Vanwert, A.; Dowd, J.; Oatis Je, J.; Middaugh, L. (2005). "Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol". Journal of Medicinal Chemistry. 48 (8): 2876–2881. doi:10.1021/jm0490989. PMID 15828826.
- Williard, R.; Middaugh, L.; Zhu, H.; Patrick, K. (2007). "Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity". Behavioural pharmacology. 18 (1): 39–51. doi:10.1097/FBP.0b013e3280143226. PMID 17218796.
- Jatlow, P; Elsworth, JD; Bradberry, CW; Winger, G; Taylor, JR; Russell, R; Roth, RH (1991). "Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion". Life sciences. 48 (18): 1787–94. doi:10.1016/0024-3205(91)90217-Y. PMID 2020260.